Adefovir dipivoxil (ADV) alone and in combination with lamivudine (LAM) suppresses LAM-resistant hepatitis B virus (HBV) replication: 16 week interim analysis

被引:20
作者
Peters, M
Hann, HW
Martin, P
Heathcote, E
Buggisch, P
Moorat, AE
Sullivan, M
Kleber, K
Ebrahimi, R
Xiong, S
Brosgart, C
机构
[1] Univ Calif San Francisco, Dept Gastroenterol, San Francisco, CA 94143 USA
[2] Thomas Jefferson Univ, Jefferson Med Coll, Div Gastroenterol & Hepatol, Philadelphia, PA 19107 USA
[3] Cedars Sinai Med Ctr, Dept Hepatol, Los Angeles, CA 90048 USA
[4] Gilead Sci Inc, Clin Res, Foster City, CA 94404 USA
[5] Toronto Western Hosp, Dept Hepatol, Toronto, ON M5T 2S8, Canada
[6] Univ Klinikum Eppendorf, Dept Med, Hamburg, Germany
[7] GlaxoSmithKline, Greenford, Middx, England
关键词
D O I
10.1016/S0168-8278(02)80013-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
13
引用
收藏
页码:6 / 7
页数:2
相关论文
empty
未找到相关数据